Clinical Computing PLC
10 October 2002
CLINICAL COMPUTING PLC
Board Changes
Clinical Computing PLC ('Clinical Computing' or 'the Company'), the
international developer of clinical information systems for the healthcare
market, announces the appointment of Alfred Elbrick as a Non-executive director
and the retirement of Professor H E de Wardener, a Non-executive director, both
with immediate effect.
Mr Elbrick, has wide-ranging international investment banking and corporate
governance experience. He is currently a director of a number of companies in
the US, the UK, Ireland and India.
Professor H E de Wardener was a joint founder of Clinical Computing PLC in 1979.
A nephrologist by trade, he provided valuable guidance on the NHS and renal
medicine.
Mr Elbrick will be the Company's third Non-executive director, with Howard
Kitchner and Neil Sinclair.
ENDS
For further information, please contact:
Jack Richardson, Chief Executive, Clinical Computing Plc Tel: 001 513 651 3803
Joe Marlovits, Finance Director, Clinical Computing Plc Tel: 020 8380 4400
Paul McManus/Peter Binns, Binns & Co PR Ltd Tel: 020 7786 9600
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.